Roberto A.Calle (Regeneron, USA)

Roberto A.Calle (Regeneron, USA)

(Participant)
Dr. Roberto Calle is an endocrinologist with over 20 years of experience in drug development in the metabolism space. He is currently an Executive Medical Director in Clinical Sciences – Internal Medicine Clinical Development Unit with Regeneron Pharmaceuticals. He is responsible for the late development metabolism portfolio for Regeneron. Dr. Calle is also the Industry Co-chair for the Metabolic Disorders Steering Committee of the Foundation of the National Institutes of Health Biomarkers Consortium, and Co-Chair of the Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) Project.